Showing results (101-110 of 266) with videos related to

Sort By:
Pageof 27
Neuromuscular Disorders : NMD|April 8, 2014
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravisJennifer Auret, Amaal Abrahams, Sharon Prince, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 31, 2015
Encephalopathy after persistent vomiting: Three cases of non-alcohol-related Wernicke's encephalopathyK Antel, N Singh, B Chisholm, et al.
Clinical Oral Implants Research|February 13, 2001
Clinical outcomes of three Parkinson's disease patients treated with mandibular implant overdenturesS M Heckmann, J G Heckmann, H P Weber
Zeitschrift Fur Geburtshilfe Und Neonatologie|August 29, 2013
Prenatal immunomodulation treatment in neonatal myasthenia gravisS Welcker, M Heckmann, R Axt-Fliedner, et al.
International Review of Neurobiology|October 16, 2025
The clinical evaluation of myasthenia gravisTarin A Europa, Sui H Wong, Jeannine M Heckmann
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 19, 1999
Reference range for serum cortisol in well preterm infantsM Heckmann, S A Wudy, D Haack, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 30, 2001
High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up studyJ M Heckmann, E B LeePan, R W Eastman
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 7, 2012
The complexity of HIV vasculopathyAlan Stanley, Sally Candy, Candyce Levin, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 29, 1998
[Botulinum toxin A in dermatology]M Heckmann, A Ceballos-Baumann, M Schaller, et al.
Cancer Research|July 15, 1990
Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activityL Schweigerer, S Breit, A Wenzel, et al.
Pageof 27